“Figuring out why some cell types are resistant is key to understanding why other cell types are so susceptible. Our latest findings offer new insight into key differences in neurons of the thoracic region, and could be harnessed to better understand why they are more resistant to the progression of ALS.” Read more in an exclusive Q&A with Dr. Tom Jessell (Project ALS Research Advisory Board) and Lora Sweeney, of Columbia and the Salk Institute, on their recently published study. Read here.

BREAKING NEWS
Dear Friends, BREAKING NEWS: The all-new drug developed by the Project ALS Therapeutics Core for the treatment of ALS, is now moving into Phase 1